Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
MediaAlpha director Yi Steven sold 12,000 shares of Class A common stock across three trades from April 13 to April 15, 2026, totaling $112,891. The sales were made under a Rule 10b5-1 plan to cover taxes tied to RSU vesting. The company recently reported Q4 2025 revenue of $291 million, slightly below the $295.02 million forecast, and disclosed a …
John Taylor Maloney Fitzgerald, President and CEO of Kingsway Financial Services Inc., purchased 211 shares at $11.85 per share on April 15, 2026, in a transaction filed with the SEC. The acquisition was made under the Kingsway America Inc. Employee Share Purchase Plan and leaves Fitzgerald with direct ownership of 1,461,182 shares, plus indirect h…
MediaAlpha Chief Revenue Officer Keith Cramer sold 10,000 Class A shares on April 15, 2026, for about $96,806 under a pre-arranged Rule 10b5-1 plan to meet tax obligations from vested RSUs. The stock trades near $9.70 with a market cap of $614.91 million. MediaAlpha's Q4 2025 results showed $291 million in revenue, slightly below the $295.02 millio…
JPMorgan Chase & Co. Chief Financial Officer Jeremy Barnum sold 5,611 shares of the bank's stock on April 15, 2026, generating roughly $1.7 million at $306.5522 per share. After the trade, Barnum's direct holdings stand at 35,460 shares. The transaction coincides with JPMorgan's advance toward completing a $38 billion loan package for Oracle Corp.'…
Ashley Bacon, JPMorgan Chase & Co.'s Chief Risk Officer, sold 7,558 shares of the bank's common stock on April 15, 2026, at $306.5535 per share for about $2.3 million, leaving her with 252,855 directly held shares. The transaction coincides with the bank's involvement in a roughly $38 billion loan package for Oracle data center projects, positive a…
Jennifer Piepszak, chief operating officer at JPMorgan Chase & Co., sold 9,136 shares of company stock on April 15, 2026, generating $2.8 million at $306.5579 per share. The transaction leaves Piepszak with 90,001 directly held shares. Separately, JPMorgan and Mitsubishi UFJ Financial Group are close to completing a $38 billion loan package to supp…
JPMorgan Chase & Co. Co-CEO for Corporate & Investment Banking Douglas B. Petno disposed of 5,660 shares on April 15, 2026, at $306.5758 per share, generating roughly $1.7 million. After the sale, Petno retains direct ownership of 381,807 shares and indirect ownership of 70,457 shares via family trusts. The disclosure arrives alongside updates on a…
Lake Marianne, CEO CCB at JPMorgan Chase & Co., sold 6,427 shares of the bank on April 15, 2026, netting $1.97 million at $306.5666 per share. The transaction leaves her with 73,726 direct shares, plus indirect holdings through GRATs and a family trust. Separately, JPMorgan is leading a roughly $38 billion loan for Oracle data centers, with most le…
JPMorgan Chase & Co. Chief Information Officer Lori A. Beer reported the sale of 3,166 shares on April 15, 2026, generating $970,659. The bank is also finalizing a $38 billion loan package to back Oracle’s data center projects and is monitoring AI-related cybersecurity issues uncovered during vendor testing. Analysts maintained upbeat ratings after…
Mary E. Erdoes, CEO of Asset & Wealth Management at JPMorgan Chase & Co., sold 12,345 shares of JPMorgan common stock on April 15, 2026, for $306.5657 per share, generating $3.78 million. After the transaction she directly holds 639,047 shares. The sale comes as JPMorgan nears completion of a $38 billion loan package for Oracle’s data center projec…
Director Patten Jarrod M. sold 3,400 shares of Strategy Inc Class A common stock on April 13, 2026, while exercising options to acquire an equal number of shares the same day. The firm also resumed sizable bitcoin purchases and completed material equity sales of its STRC and MSTR stock during an early-April window, with analysts reiterating a Buy o…
Virco MFG CORPORATION (NASDAQ:VIRC) Executive Vice President Douglas A. Virtue bought 16,027 shares in two trades on April 14-15, 2026, paying between $6.07 and $6.09 per share for a total outlay of $97,517. The purchases bring his direct holdings to 877,866 shares. The stock trades at $6.09 with a market capitalization of $95.91 million and is ide…
David Spector, Chairman and CEO of PennyMac Financial Services (PFSI), sold 10,000 shares on April 14, 2026 under a prearranged Rule 10b5-1 plan, generating roughly $928,279. The transactions leave Spector with both indirect and direct holdings in the company, including restricted stock units. The sale occurs against a backdrop of a 30% year-to-dat…
Cytokinetics Inc (NASDAQ:CYTK) President and CEO Robert I. Blum sold 7,500 shares on April 15, 2026, for $65.38 per share, a transaction totaling $490,349. After the sale, Blum directly holds 415,330 shares; he also retains indirect holdings through two irrevocable trusts. The sale coincides with CYTK trading close to its 52-week high and a string …
Globalstar Vice President and Chief Financial Officer Rebecca Clary sold 4,037 shares of the company on April 15, 2026, for about $322,354. The sale followed the vesting on April 14 of a performance share award that delivered 9,524 voting common shares with a reported value of $0. After these moves Clary directly holds 115,741 Globalstar shares. Se…
Cytokinetics Executive Vice President and Chief Commercial Officer Andrew Callos sold 7,449 shares of common stock on April 15, 2026, for $66.02 per share, realizing $491,782. The transaction occurred near the stock's 52-week high and follows strong analyst endorsements tied to the Myqorzo (aficamten) program and the upcoming Phase 3 ACACIA trial.
Conagra Brands director Lenny Richard H purchased 25,000 shares on April 14, 2026, for $14.34 per share, totaling $358,500. The trade comes as the stock trades close to its 52-week low and after the company announced a CEO transition. Analysts have responded with divergent ratings and price targets; the company also offers a substantial dividend yi…
RA Capital Healthcare Fund LP disposed of 740,789 shares of Vor Biopharma Inc (NASDAQ:VOR) common stock across three days in mid-April, realizing roughly $11.8 million. After the trades, the fund retains 3,197,619 shares. The stock has fallen about 47% over six months even as the company progresses a Phase 3 Sjögren’s disease trial and receives mul…
Conagra Brands director John J. Mulligan purchased 17,500 shares on April 14, 2026, investing $250,402 at $14.3087 per share. The transaction occurred while the stock sits close to its 52-week low and amid an announced CEO succession. Analysts have responded with fresh coverage and target updates, underscoring questions about valuation as the compa…
Rambus INC director Rao Meera sold 8,538 shares on April 14, 2026, for $118.08 per share, totaling $1,008,167. The transaction was made under a Rule 10b5-1 trading plan adopted November 14, 2025. The company recently reported Q4 2025 EPS in line with expectations and slightly beat revenue, introduced HBM4E Memory Controller IP, and disclosed a CFO …
Heath Tarbert, president of Circle Internet Group, sold 14,900 shares of Class A common stock on April 13, 2026, in a series of trades that generated roughly $1.42 million. The transactions were carried out under a 10b5-1 trading plan. Circle has also rolled out a managed stablecoin settlement product while analysts remain divided on the company's …
Didier Wimmers, Executive Vice President of R&D at Aehr Test Systems, executed two insider sales totaling 5,400 shares and $385,731 in mid-April 2026. The trades occurred as AEHR stock traded close to a 52-week high after a year of strong gains and record quarterly bookings, while the company reported mixed fiscal third-quarter results.
Disc Medicine (NASDAQ: IRON) Chief Medical Officer William Jacob Savage sold 5,731 shares of common stock on April 13, 2026 under a Rule 10b5-1 trading plan, generating about $380,448 in proceeds. The disposal occurred in two tranches and leaves Savage with 79,480 shares directly held. The company, whose shares have climbed more than 70% in the pas…
Village Super Market Inc. Executive Vice President and Secretary John Sumas sold 12,703 Class A shares on April 14, 2026, for a total of $524,672. The sale occurred at prices between $40.945 and $41.87. After the transaction Sumas retains 102,938 shares. The stock is trading at $41.22, with solid gains over recent periods and valuation metrics show…
JPMorgan Chase & Co. Chairman and CEO James Dimon sold 130,488 shares of common stock on April 15, 2026, generating about $40.0 million. The transaction leaves him with substantial direct and indirect holdings. The bank is also close to completing a $38 billion loan syndication for Oracle data center projects, testing Anthropic's Mythos AI, and not…
